Current Report Filing (8-k)
19 Outubro 2021 - 9:59AM
Edgar (US Regulatory)
0000895665
false
0000895665
2021-10-19
2021-10-19
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event Reported): October
19, 2021 (October 18, 2021)
Clearday,
Inc.
(Exact
Name of Registrant as Specified in Charter)
Delaware
|
|
0-21074
|
|
77-0158076
|
(State
or Other Jurisdiction
of
Incorporation)
|
|
(Commission
File
Number)
|
|
(I.R.S.
Employer
Identification
Number)
|
8800
Village Drive, Suite 106, San Antonio, TX 78217
(Address
of Principal Executive Offices) (Zip Code)
(210)
451-0839
(Registrant’s
telephone number, including area code)
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock, par value $0.001
|
|
CLRD
|
|
OTCQB
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
1.01 Entry into a Material Definitive Agreement.
Clearday,
Inc. (the “Company” or “Clearday”),
entered into an agreement, dated as of October 18, 2021
(the “EMC Agreement”), with Emerging Markets Consulting, LLC (“EMC”)
to provide certain investor relations, including the distribution of press releases and other Company information. EMC Agreement provides
for a term that is month to month. The initial fee under the EMC Agreement is $150,000. The Company has agreed to indemnify EMC and take
appropriate actions to comply with Section 17(b) of the Securities Act of 1933, as amended. EMC will not act as a broker or dealer and
will not receive any transaction based compensation.
The
foregoing description of the EMC Agreement is a summary only, is not intended to be complete, and is qualified in its entirety by reference
to the full text of the EMC Agreement, which is filed as an exhibit to this Current Report on Form 8-K.
Forward
Looking Statements
This communication contains forward-looking statements
(including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act
of 1933, as amended) concerning the Company. These statements may discuss goals, intentions and expectations as to future plans, trends,
events, results of operations or financial condition, or otherwise, as well as assumptions made by, and information currently available
to, management and may include, but are not limited to, statements regarding the Company’s
opportunities with its innovative products and services, and statements regarding the nature, potential approval and commercial success
of Clearday and its product line, the effects of having shares of its capital stock traded on the OTC Market, the Company’s financial
resources and cash expenditures. Forward-looking statements generally include statements that are predictive in nature and depend
upon or refer to future events or conditions, and include words such as “may,” “will,” “should,”
“would,” “expect,” “anticipate,” “plan,” “likely,” “believe,”
“estimate,” “project,” “intend,” and other similar expressions. Statements that are not historical
facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks
and uncertainties and are not guarantees of future performance. Actual results may differ
materially from those indicated by forward-looking statements
as a result of various factors, risks and uncertainties. These factors, risks and uncertainties
include, but are not limited to: the risks regarding the Company and its business, generally; risks related to the Company’s
ability to correctly estimate and manage its operating expenses, including with respect to future
financial and operating results; the ability to develop its innovate non-acute care businesses and the acceptance of its proposed
products and services; the ability of the Company to protect its intellectual property rights; competitive responses to the Company’s
businesses, including its innovative non-acute care business; unexpected costs, charges or
expenses; regulatory requirements or developments; changes in capital resource requirements; and legislative, regulatory, political and
economic developments. The foregoing review of important factors that could cause actual events to differ from expectations should not
be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including the risk
factors included in the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on
Form 8-K filed with the SEC and the registration statement regarding the Company’s previously announced merger, that was filed
and declared effective(registration no. 333-256138). The Company can give no assurance that
the actual results will not be materially different than those based on the forward looking statements. The
forward-looking statements included in this communication represent the Company’s views as of the date hereof. These forward-looking
statements should not be relied upon as representing the Company’s views as of any date subsequent to the date hereof. Except
as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any
other forward-looking statements, whether as a result of new information, future events or otherwise.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
CLEARDAY,
INC.
|
|
|
|
|
By:
|
/s/
James Walesa
|
|
Name:
|
James
Walesa
|
|
Title:
|
Chief
Executive Officer
|
|
|
|
Dated
October 19, 2021
|
|
|
Superconductor Technolog... (NASDAQ:SCON)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Superconductor Technolog... (NASDAQ:SCON)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
Notícias em tempo-real sobre Superconductor Technologies Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Clearday, Inc.